Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells.

Darche FF., Rivinius R., Köllensperger E., Leimer U., Germann G., Seckinger A.

Animal Study on Cardiovascular Disease, published in Life Sci (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Life Sci (2019)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
31291594
DOI
10.1016/j.lfs.2019.116620

Abstract (original English)

Cell-based biological pacemakers aim to overcome limitations and side effects of electronic pacemaker devices. We here developed and tested different approaches to achieve nodal-type differentiation using human adipose- and bone marrow-derived mesenchymal stem cells (haMSC, hbMSC). haMSC and hbMSC were differentiated using customized protocols. Quantitative RT-PCR was applied for transcriptional pacemaker-gene profiling. Protein membrane expression was analyzed by immunocytochemistry. Pacemaker current (I f ) was studied in haMSC with and without lentiviral HCN4-transduction using patch clamp recordings. Functional characteristics were evaluated by co-culturing with neonatal rat ventricular myocytes (NRVM). Culture media-based differentiation for two weeks generated cells with abundant transcription of ion channel genes (Ca v 1.2, NCX1), transcription factors (TBX3, TBX18, SHOX2) and connexins (Cx31.9 and Cx45) characteristic for cardiac pacemaker tissue, but lack adequate HCN transcription. haMSC-derived cells revealed transcript levels, which were closer related to sinoatrial nodal cells than hbMSC-derived cells. To substitute for the lack of I f , we performed lentiviral HCN4-transduction of haMSC resulting in stable I f . Co-culturing with NRVM demonstrated that differentiated haMSC expressing HCN4 showed earlier onset of spontaneous contractions and higher beating regulari

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsBiological ClocksBone Marrow CellsCell DifferentiationCoculture TechniquesHumansHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMesenchymal Stem CellsMuscle Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research